Skip to content

Erasca, Inc. ERAS Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
Amgen logo
AmgenAMGN
$12.76B+12.0%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$14.48M+10.3%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$293K+29,200%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$61M-14.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.94M-60.1%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s other non-current assets?
Erasca, Inc. (ERAS) reported other non-current assets of $1.45M in Q1 2026.
How has Erasca, Inc.'s other non-current assets changed year-over-year?
Erasca, Inc.'s other non-current assets decreased by 44.7% year-over-year, from $2.62M to $1.45M.
What is the long-term trend for Erasca, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Erasca, Inc.'s other non-current assets has grown at a 26.4% compound annual growth rate (CAGR), from $451K to $1.45M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.